Cleared Traditional

SOMNOscreen plus (K201054) - FDA 510(k) Clearance

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2020
Decision
113d
Days
Class 2
Risk

K201054 is an FDA 510(k) clearance for the SOMNOscreen plus. Classified as Standard Polysomnograph With Electroencephalograph (product code OLV), Class II - Special Controls.

Submitted by Somnomedics GmbH (Randersacker, DE). The FDA issued a Cleared decision on August 12, 2020 after a review of 113 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1400 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Somnomedics GmbH devices

Submission Details

510(k) Number K201054 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 21, 2020
Decision Date August 12, 2020
Days to Decision 113 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
35d faster than avg
Panel avg: 148d · This submission: 113d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code OLV Standard Polysomnograph With Electroencephalograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Acquire, Display, Store, And Archive Electroencephalographic Signals From The Brain And Other Signals (such As Electromyography, Respiratory And/or Oximetry Signals) For Sleep Recordings. May Also Be Used To Allow On-screen Review, User-controlled Annotation And User-controlled Marking Of Data.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - OLV Standard Polysomnograph With Electroencephalograph

All 18
Devices cleared under the same product code (OLV) and FDA review panel - the closest regulatory comparables to K201054.
Noxturnal Web
K241288 · Nox Medical Ehf · Dec 2024
HomeSleepTest (HST, HST REM+)
K240700 · Somnomedics GmbH · Dec 2024
Cerebra Sleep System
K213007 · Cerebra Medical , Ltd. · Jul 2022
ApneaTrak
K192624 · Cadwell Industries, Inc. · Feb 2020
Serenity Piezo Sensor, Serenity Thermocouple Sensor
K181709 · Neurotronics, Inc. · Nov 2018
Serenity Body Position Sensor, Serenity RIP Sensors
K173868 · Neurotronics, Inc. · Jul 2018